CD2AP inhibits metastasis in gastric cancer by promoting cellular adhesion and cytoskeleton assembly. Issue 4 (28th January 2020)

• Record Type: Journal Article
• Authors: Xie, Wangkai; Chen, Chao; Han, Zheng; Huang, Jingjing; Liu, Xin; Chen, Hongjun; Zhang, Teming; Chen, Sian; Chen, Chenbin; Lu, Mingdong; Shen, Xian; Xue, Xiangyang
• Is Part Of: Molecular carcinogenesis. Volume 59:Issue 4(2020)
• Page Start: 339
• Page End: 352
• Publication Date: 2020-01-28
• Subjects: CD2AP -- cytoskeleton -- gastric cancer -- intercellular adhesion -- invasion -- migration; Carcinogenesis -- Molecular aspects -- Periodicals; 616.994071
• DOI: 10.1002/mc.23158
• Languages: English
• ISSNs: 0899-1987

Abstract

Abstract: Diffuse gastric cancer (DGC) is a lethal malignancy lacking effective systemic therapy. Among the most provocative recent results in DGC has been that the alter of the cellular cytoskeleton and intercellular adhesion. CD2‐associated protein (CD2AP) is one of the critical proteins regulating cytoskeleton assembly and intercellular adhesion. However, no study has investigated the expression and biological significance of CD2AP in gastric cancer (GC) to date. Therefore, the aim of our study was to explore if the expression of CD2AP is associated with any clinical features of GC and to elucidate the underlying mechanism. Immunohistochemistry of 620 patient tissue samples indicated that the expression of CD2AP is downregulated in DGC. Moreover, a low CD2AP level was indicative of poor patient prognosis. In vitro, forced expression of CD2AP caused a significant decrease in the migration and invasion of GC cells, whereas depletion of CD2AP had the opposite effect. Immunofluorescence analysis indicated that CD2AP promoted cellular adhesion and influenced cell cytoskeleton assembly via interaction with the F‐actin capping protein CAPZA1. Overall, the upregulation of CD2AP could attenuate GC metastasis, suggesting CD2AP as a novel biomarker for the prognosis and treatment of patients with GC.